Jeffrey E. Kropf

Kinase inhibition in autoimmunity and inflammation

Control of Inflammasome Activation by Phosphorylation

Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules

PROTAC targeted protein degraders: the past is prologue

A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells

The PI3K Pathway in Human Disease

Electrochemical Allylation Reactions of Simple Imines in Aqueous Solution Mediated by Nanoscale Zinc Architectures

A GPT‐4 Reticular Chemist for Guiding MOF Discovery**

Design of MOFs with Absolute Structures: A Case Study

Coordinative Alignment in the Pores of MOFs for the Structural Determination of N-, S-, and P-Containing Organic Compounds Including Complex Chiral Molecules

DAMP-sensing receptors in sterile inflammation and inflammatory diseases

CuSO₄–Glucose for in Situ Generation of Controlled Cu(I)–Cu(II) Bicatalysts: Multicomponent Reaction of Heterocyclic Azine and Aldehyde with Alkyne, and Cycloisomerization toward Synthesis of N-Fused Imidazoles

Digital Reticular Chemistry

Synthesis of imidazo[1,2-a]pyridines: a decade update

Synthetic Organic Electrochemical Methods Since 2000: On the Verge of a Renaissance

Phase 2 study of idelalisib and entospletinib: pneumonitis limits combination therapy in relapsed refractory CLL and NHL

Discovery of GS-9973, a Selective and Orally Efficacious Inhibitor of Spleen Tyrosine Kinase

Imidazo[1,2-a]pyrazine diaryl ureas: Inhibitors of the receptor tyrosine kinase EphB4

Studies on a Total Synthesis of the Microbial Immunosuppresive Agent FR901483